CX815

CAS No. 109628-27-5

CX815( CX-815 | CX 815 | NSC 120213 )

Catalog No. M10374 CAS No. 109628-27-5

A novel potent, selective CXCR2 inhibitor with IC50 of 0.4 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 46 In Stock
10MG 77 In Stock
25MG 130 In Stock
50MG 182 In Stock
100MG 275 In Stock
200MG Get Quote In Stock
500MG 675 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CX815
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent, selective CXCR2 inhibitor with IC50 of 0.4 nM.
  • Description
    A novel potent, selective CXCR2 inhibitor with IC50 of 0.4 nM; displays>1,000-fold selectivity over CXCR4 (IC50>50 uM); inhibits cell proliferation of H1299 and H460 cells with IC50 of 3.5 and 4.1 uM in MTT assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CX-815 | CX 815 | NSC 120213
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    109628-27-5
  • Formula Weight
    327.398
  • Molecular Formula
    C18H17NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (304.52 mM)
  • SMILES
    CC1=CC=C(C=C1)S(=O)(=O)NC2=C3C(=CC(=C2)OC)C=CC=N3
  • Chemical Name
    N-(6-methoxyquinolin-8-yl)-4-methylbenzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ha H, et al. J Chem Inf Model. 2015 Aug 24;55(8):1720-38.
molnova catalog
related products
  • LMD-A

    LMD-A (CCR8 antagonist LMD-A) is a highly potent, small molecule antagonist of chemokine receptor CCR8 with EC50 of 2.5 nM.

  • BX471

    BX471 is a potent, selective, non-peptide CCR1 antagonist with Ki of 1 nM for hCCR1, displays 100 times less affinity for rat CCR1.

  • SX-517

    A potent, specific, noncompetitive dual CXCR1 and CXCR2 antagonist with IC50 of 38 nM (vs. CXCL1) and 36 nM (vs. CXCL8), respectively.